Authors: Strous, RD Spivak, B Yoran-Hegesh, R Maayan, R Averbuch, E Kotler, M Mester, R Weizman, A

Citation: Rd. Strous et al., Analysis of neurosteroid levels in attention deficit hyperactivity disorder, IN J NEUROP, 4(3), 2001, pp. 259-264

Authors: Spivak, B Vered, Y Yoran-Hegesh, R Graff, E Averbuch, E Vinokurow, S Weizman, A Mester, R

Citation: B. Spivak et al., The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivitydisorder, HUM PSYCHOP, 16(4), 2001, pp. 333-337

Authors: Spivak, B Vered, Y Yoran-Hegesh, R Averbuch, E Mester, R Graf, E Weizman, A

Citation: B. Spivak et al., Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder, ACT PSYC SC, 99(4), 1999, pp. 300-304

Authors: Blumensohn, R Yoran-Hegesh, R Golubchik, P Mester, R Fluhr, H Hermesh, H Weizman, A

Citation: R. Blumensohn et al., Elevated serum creatine kinase activity in adolescent psychiatric inpatients on admission, INT CLIN PS, 13(6), 1998, pp. 269-272